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Homozygous deletions or loss of heterozygosity (LOH) at human chromosome band 3p12 are consistent features of lung and
other malignancies, suggesting the presence of a tumor suppressor gene(s) (TSG) at this location. Only one gene has been
cloned thus far from the overlapping region deleted in lung and breast cancer cell lines U2020, NCI H2198, and HCC38. It is
DUTT1 (Deleted in U Twenty Twenty), also known as ROBO1, FLJ21882, and SAX3, according to HUGO. DUTT1, the human
ortholog of the ﬂy gene ROBO, has homology with NCAM proteins. Extensive analyses of DUTT1 in lung cancer have not
revealed any mutations, suggesting that another gene(s) at this location could be of importance in lung cancer initiation and
progression. Here, we report the discovery of a new, small, homozygous deletion in the small cell lung cancer (SCLC) cell line
GLC20, nested in the overlapping, critical region. The deletion was delineated using several polymorphic markers and three
overlapping P1 phage clones. Fiber-FISH experiments revealed the deletion was approximately 130 kb. Comparative genomic
sequence analysis uncovered short sequence elements highly conserved among mammalian genomes and the chicken genome.
The discovery of two EST clusters within the deleted region led to the isolation of two noncoding RNA (ncRNA) genes. These
were subsequently found differentially expressed in various tumors when compared to their normal tissues. The ncRNA and
other highly conserved sequence elements in the deleted region may represent miRNA targets of importance in cancer initia-
tion or progression. Published 2006 Wiley-Liss, Inc.y
INTRODUCTION
Loss of function of tumor suppressor genes
(TSGs) is a fundamental genetic change involved in
the origin and pathogenesis of human tumors (Knud-
son, 1971; Marshall, 1991). TSGs have a recessive
mode of action; therefore, both copies need to be
inactivated to produce a phenotypic effect. This fre-
quently occurs when one allele is hit by a mutation
or silenced through promoter region hypermethyl-
ation and the other is lost generally because of a large
chromosomal deletion. In some instances, both al-
leles become inactivated by genetic loss as a conse-
quence of a homozygous deletion. Sub-lethal homo-
zygous deletions are frequently smaller than their
heterozygous counterparts. This characteristic makes
them a useful tool for localizing TSGs.
Cytogenetic and molecular deletion mapping studies
have long implicated chromosome bands 3p25-26,
3p21.3, and 3p12-14 as harboringTSGs involved inmul-
tiple forms of human cancers, including lung cancers
(Whang-Peng et al., 1982; Kok et al., 1987; Zbar,
1989; Kok et al., 1997; Zabarovsky et al., 2002).
The FHIT gene, residing in 3p14.2, is subjected
to homozygous deletions and alterations of its
mRNA in many sporadic cancers (Huebner et al.,
1998). Frequent allele loss at the FHIT locus has
been found in low-grade breast cancer. 3p12 is a
particularly signiﬁcant region (Lerman and Minna,
2000), as demonstrated by functional studies (Lott
et al., 1998; Lovell et al., 1999). Rabbitts et al.
(1990) reported a homozygous deletion at the D3S3
locus in the U2020 cell line. It spans about 8 Mb
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and is ﬂanked by the microsatellite markers D3S1284
and D3S1276 (Drabkin et al., 1992; Latif et al.,
1992). Other nested or overlapping homozygous
deletions have also been identiﬁed in this region.
Todd et al. (1997) reported a homozygous deletion
that overlaps the U2020 region and is ﬂanked by
the microsatellite markers D3S1254 and D3S1776.
Another overlapping homozygous deletion was
found in breast cancer cell line HCC38. It spans
about 5 Mb and is ﬂanked by the microsatellite
markers D3S2537 and D3S2527 (Sundaresan et al.,
1998a). In small cell lung cancer (SCLC) cell line
NCI-H2198, a much smaller deletion was found,
which contains the microsatellite markers D3S1274,
D3S2498, and D3S4492 (telomere to centromere,
Sundaresan et al., 1998a).
The DUTT1 (Deleted in U Twenty-Twenty) gene
was also isolated from this low gene-density region
of chromosome 3 (Sundaresan et al., 1998b). DUTT1
gene expression is impaired by hypermethylation
of its promoter in primary cancers of kidney and
breast, but is hypermethylated to a lesser extent in
lung cancers.
In this paper, we describe a new, homozygous
deletion at 3p12 identiﬁed in the SCLC cell line
GLC20. It spans 130 kb around the D3S1274
microsatellite marker, and it partly overlaps with
the NCI-H2198 deletion. The deletion affects exon
2 and the ﬂanking introns of the DUTT1 gene. In
the second intron, we discovered two novel tran-
scripts with the same orientation as DUTT1. Both
are polyadenylated, have small ORFs without any
known homologues or orthologues, and likely do
not encode proteins. Both are putative noncoding
(nc) RNA genes, which we found overexpressed in
lung and breast cancers, and underexpressed in
kidney cancer as compared to paired normal tissue.
The deleted region also contained some sequence
elements highly evolutionarily conserved among
different genomes (Bejerano et al., 2004; Hillier
et al., 2004).
MATERIALS ANDMETHODS
Human Tissues and DNA
Signed, informed consent was obtained from all
human donors in the study, according to the NCI
institutional review board approved protocol. Tis-
sues were taken from patients not treated by radio-
or chemotherapy. Primary tumors were classiﬁed
by the UICC-TNM (International Union Against
Cancer—Tumor-Node-Metastasis) staging system
according to Sobin et al. (2002). Histological typing
of tumors was performed in accordance with inter-
national protocols (Travis et al., 1999; Tavassoli
and Devilee, 2003; Eble et al., 2004). Eight renal
cell carcinoma cases were represented by clear cell
histology type only, ten breast cancers, including
mainly ductal breast carcinomas (nine cases and
one case of lobular cancer), four nonsmall cell lung
cancers (NSCLC), consisting predominantly of
adenocarcinomas (three cases and one case of squa-
mous-cell lung cancer).
Cell Lines and DNA
The lung cancer cell lines NCI-H750, NCI-
H2198, and NCI-H1450 were obtained from ATCC
(Manassas, VA). U2020 DNA was kindly provided
by Dr. Pamela Rabbits (MRC, Cambridge, United
Kingdom). SCLC cell line, GLC20, was estab-
lished from a primary tumor biopsy (De Leij et al.,
1985), and is known to harbor a 440-kb homozy-
gous deletion at 3p21.3 (Kok et al., 1994).
For most of our experiments, we focused on
GLC20 (established in the Netherlands; De Leij
et al., 1985) and NCI-H2198 (established in USA;
Phelps et al., 1996). With the exception of the
ﬁber- ﬂuorescence in situ hybridization (FISH) ex-
periment that was performed in the Netherlands
on the GLC20 cell line only, all PCR and reverse-
transcriptase (RT)-PCR experiments presented here
were run separately but in parallel in the Frederick
(on H2198) and Groningen (on GLC20) laborato-
ries, for independent mapping of the new deletion.
EST Clones
ESTclones were purchased from the I.M.A.G.E.
Consortium (http://image.llnl.gov/).
PCR
PCR primers were from BioServe Biotechnologies
(Laurel, MD). PCR reactions were performed using
the PTC-100TM thermalcycler (MJ Research Inc.,
Bio-Rad Laboratories, Waltham, MA), in a total reac-
tion volume of 12.5 ll, containing 100 ng of genomic
DNA, 12.5 pmol of each primer, 200 lM dNTPs, and
1.5 mM MgCl2. The PCR cycles were as follows:
958C, 5 min; (958C, 30 sec, [Ta varying between
55 and 648C], 30 sec, 728C, 30 sec) for 35 cycles;
728C, 7 min. PCR products were run on 3% or 4%
NuSieve 3:1 agarose gel (Cambrex, Baltimore, MD)
and were stained with ethidium bromide (Sigma, St.
Louis, MO). Gel analysis was performed with the
ViTran software (Biokom, Russia).
Reverse-Transcriptase and Real-Time
Quantitative PCR
RT-PCR was performed with the BD SMARTTM
RACE cDNA Ampliﬁcation Kit (Clontech, Palo Alto,
CA), according to the manufacturer’s instruction.
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Real-time quantitative (qRT)-PCR was performed
with the GenePakTM Real-Time PCR Core Kit
(IsoGen, Russia). The reaction volume was 21 ll
(SYBR Green concentration 13). The PCR ther-
mal proﬁle consisted of an initial denaturation of
3 min at 958C followed by 70 cycles of 15 sec at
958C, 15 sec at 528C (for W91914 primers F3 and
R3) or 558C (for B2M primers), and 15 sec at 728C.
All signals were detected between 30 and 40 cycles.
Ampliﬁcation, detection, and data analysis were
performed with an iCycler IQ real-time detection
system (Bio-Rad). Statistical analysis was per-
formed with the REST software (http://www.
gene-quantiﬁcation.de/).
When an RT-PCR was performed for a protein-
encoding gene (RBM5) with intron-ﬂanking pri-
mers yielding different bands for DNA and RNA,
similar intensities were observed for both the nor-
mal tissues and tumor cell lines (data not shown).
Differences in band intensity seen between normal
tissues and tumor cell lines were therefore caused
by a difference in the amounts of RNA.
qRT-PCR results were analyzed with the compar-
ative DDCt method as described (Senchenko et al.,
2003): Delta Delta Ct ¼ (DeltaCt W91914 in tumor 
DeltaCt W91914 in norm)  (DeltaCt B2M in tumor 
DeltaCt B2M in norm). 2
-DDCt ¼ RQ, relative expres-
sion level in tumor as compared that of normal.
Southern Blot
Southern blotting was done according to Sambrook
et al. (1998). Brieﬂy, genomic DNA samples were
digested overnight with EcoRI in the presence of
1% spermidine, precipitated with Na acetate, re-
suspended in TE buffer, loaded on a 1% agarose
gel and run overnight at 30 V. The gel was then de-
natured and DNA transferred overnight in NaOH
(0.4 N). The membrane was washed in 23 SSC and
dried for 3 hr at 808C in a vacuum oven. Hybridiza-
tion was carried out at 608C overnight. Washes
were done in 23 SSC, 1%–0.1% SDS at 658C.
Northern Blot
Northern blotting was performed with Clontech
Human Multiple Tissue Northern Blots 7760-1
(Clontech). Hybridization was carried out at 428C
overnight. Washes were done ﬁrst in 23 SSC, 1%
SDS and then 23 SSC, 0.1% SDS at 658C.
Probe Labeling
W91914 and H51703 cDNAs were excised with
EcoRI/PacI from the modiﬁed polylinker of the
pT7T3D vector (Pharmacia, North Peapack, NJ),
and radioactive probes were prepared by 32P-label-
ing with random primers (Rediprime DNA Label-
ing System, Amersham, Arlington Heights, IL).
P1 Library Screening
We performed a PCR-screening of a P1 genomic
library (Genome Systems, St. Louis, MO) and as-
sembled a contig of P1 clones that would represent
the entire deleted region (Fig. 5).
The initial screening of the P1 Human Library
(Genome Systems, St. Louis, MO) was performed
with PCR primers placed within EST W91914, and
it resulted in the identiﬁcation of three clones des-
ignated P1-97, P1-98, and P1-99. A second round
of PCR, with primers placed at the Sp6-end of P1-
98, yielded a fourth clone P1-80.
Both ends of each P1 clone were sequenced. PCR
reactions performed with primers placed at both
ends of each P1 clone (Fig. 3, Table 1) allowed the
contig assembly.
Fiber Fluorescence In Situ Hybridization
Preparations for ﬁber-FISH analysis were per-
formed essentially according to Giles et al. (1997).
GLC20 cells were spun down by centrifugation at
1,200 rpm for 10 min, and resuspended in distilled
water to a concentration of 1–5 3 105 cells per ml.
Microscope slides were coated by incubating the
slides for 30 min with 100 ll of 5% 3-aminopropyl-
ethoxy-silane in acetone, washing with distilled
water and air drying. The cell suspension was then
spread over the coated slide and air dried. Exposure
of chromatin threads from the nuclei was obtained
by applying two drops of 0.5% SDS, 50 mM EDTA,
0.2M Tris HCl, pH 7.0 lysis solution on 24 mm 3
60 mm cover slips. The microscope slides were then
placed upside down on top of the coverslips. The
slides were then turned over and kept with the cov-
erslip on for up to 30 sec. The coverslips were then
slid off gently and preparations were air dried.
Bicolor FISH analysis was performed on these
preparations using differentially labeled P1 phages
and routine FISH procedures, essentially as described
by Driesen et al. (1991).
Sequencing
Sequencing was performed on an ABI 373 Stretch
Automated DNA Sequencer (Applied Biosystems,
Foster City, CA).
Computational Analysis
The following WWW-based servers and databases
were used. Global and pairwise sequence alignments:
BLAST (http://www.ncbi.nlm.nih.gov/BLAST/) and
BLAT (http://genome.ucsc.edu/cgi-bin/hgBlat); mul-
Genes, Chromosomes & Cancer DOI 10.1002/gcc
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tiple sequence alignment: ClustalW (http://www.ebi.
ac.uk/clustalw/index.html); CpG island search: CpG
Plot (http://www.ebi.ac.uk/emboss/cpgplot/index.html?);
analysis of nonredundant sets of gene-oriented clus-
ters: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?
db ¼ unigene; genome annotations: The Human
Genome Browser Gateway (http://genome.ucsc.edu/
cgi-bin/hgGateway), Acembly (http://www.ncbi.nih.
gov/IEB/Research/Acembly/index.html), and Ensembl
(http://ensembl.org); prediction of complete gene struc-
tures in genomic sequences (exons, introns, promoters,
and poly-adenylation signals): GenScan (http://genome.
dkfz-heidelberg.de/cgi-bin/GENSCAN/genscan.
welcome.pl); analysis of protein features: Psort (http://
psort.nibb.ac.jp) and Pfam (http://pfam.wustl.edu);
search of possible miRNA target sites: DIANA (http://
diana.pcbi.upenn.edu/cgi-bin/micro_t.cgi); analysis
of known miRNA sequence: The miRNA Registry
(http://www.sanger.ac.uk/Software/Rfam/mirna/index.
shtml).
RESULTS
Discovery of a New Homozygous Deletion in 3p12.3
We performed PCR experiments on genomic
DNA from a panel of lung cancer cell lines with
primers located in seven ESTs (T02956, H77734,
D81026, T02864, T64897, W91914, and Z41019),
which map between the genetic markers D3S1274
(alias AFM154xa7, Z16684) and D3S1604 (alias
AFM316vc1, Z24325), Table 1. Among the cell lines
analyzed, only U2020 and NCI-H2198 were known
to harbor a homozygous deletion at 3p12.
All ESTs, except T02956 and D81026, were
found deleted in the U2020 cell line (Table 1 and
data not shown). W91914 was found deleted also in
the small cell lung cancer (SCLC) cell lines H2198
and GLC20 (Fig. 1A). The latter was previously
not known to harbor deletions in this region of 3p.
This serendipitous result was conﬁrmed by South-
ern blotting experiments (Fig. 1B), and the dele-
tion was designated the ‘‘GLC20-3p12 deletion’’.
Figure 1. A novel homozygous deletion at 3p12.3 in the SCLC cell
lines GLC20 and H2198. (A) Genomic PCR with W91914 primers on
normal (CEPH) DNA and cancer cell lines; 100-bp ladder Invitrogen.
(B) Southern blot performed with 10 lg of genomic DNA digested with
EcoRI. Probe: EST W91914. Lane 1: GLC20, lanes 2 and 3: normal indi-
viduals, lane 4: molecular marker (Invitrogen). The two normal individu-
als differ for a EcoRI polymorphism.
Figure 2. PCR experiments to investigate the position of several
microsatellite markers with respect to the GLC20-3p12 homozygous
deletion and the four P1 clones that cover the deletion. Microsatellites
are ordered (top to bottom) from the more telomeric to the more cen-
tromeric. PCR primers are listed in Table 1.
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Characterization of the Deletion Breakpoints
The exact genomic location and extent of the
GLC20-3p12 deletion were determined by PCR
experiments using several microsatellite genetic
markers (Table 1, Fig. 2). The deletion was found
to be located around the D3S1274 marker in both
the NCI-H2198 and the GLC20 cell lines (Fig. 2).
PCR-screening of a P1 genomic library (Genome
Systems, St. Louis, MO) allowed the assembly of a
P1-clone contig representing entirely the deleted
region (Fig. 3, Table 1, and Fig. 5). P1-97 contains
the proximal boundary of the deletion and is centro-
meric to P1-98, which overlaps, for a short region,
with P1-80, containing the telomeric boundary.
Several ESTs were positioned in the contig by
PCR (Figs. 4 and 5). EST AW861295 was also
shown, by PCR, to be homozygously deleted in
GLC20-3p12. It mapped to P1-98 (Fig. 4), but was
not investigated further, because a BLAST search
did not retrieve any other overlapping ESTclones.
To corroborate the PCR ﬁndings and verify the
contig location with respect to the centromeric and
telomeric ends of 3p, the P1 clones were used in
ﬁber-FISH experiments. These were conducted
on normal DNA and DNA from the GLC20 cell
line (Fig. 6), using the referral clones P1-26 and
P1-27, previously described by Latif et al. (1992).
The ﬁber-FISH approach was used in addition to
the EST and microsatellite PCR experiments, be-
cause it allowed physical imaging of the markers’ re-
spective position. Using BLAT, the genomic posi-
tion of the deletion borders, P1-97 Sp6-end and P1-
80 T7-end, (deposited under GenBank Accession
numbers DQ100613 and DQ100614, respectively)
were retrieved. Their positions on chromosome 3
were 78.918,087-78.918,453, and 79.117,734-79.118,091
respectively, according to theHumanGenomeBrowser,
May 2004, hg 17 assembly.
The extension of the deletion is hence less than
200.005 bp (i.e., the distance between the two
anchoring markers P1-80 T7-end and P1-97 Sp6-
end). By means of the ﬁber-FISH experiments, the
Figure 3. PCR experiments with primers located within the ends of
each P1 clone were performed to build a P1 clone contig and to identify
the deletion boundaries. The SCLC cell lines GLC20, U2020, and NCI-
H2198 were investigated. PCR primers are listed in Table 1.
Figure 4. PCR experiments with primers located within the ESTs
deleted in the GLC20-3p12 homozygous deletion and represented in
the P1 contig. PCR primers are listed in Table 1.
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deletion was determined to be 110–130 kb (see
legend of Fig. 6)
Status of the DUTT1 Gene in the GLC20-3p12
Homozygous Deletion
Using PCR primers placed within the exonic
sequence of the DUTT1 gene (Table 1), we deter-
mined that the GLC20-3p12 homozygous deletion
removed one exon of DUTT1 (exon 2 of DUTT1
variant 2, GenBank Z95705, NM_133631, corre-
sponding to cDNA residues 1021-1345, Fig. 7), and
it comprised entirely the region between introns 1
and 2 of the same gene (Fig. 5). These ﬁndings
were conﬁrmed by RT-PCR on DUTT1 cDNA pre-
pared from GLC20 cells. The deletion caused the
loss of amino acids 19-128 (as described for the cell
line H2198 by Sundaresan et al. (1998b)). These
results were also conﬁrmed by PCR on YAC clones
912A11, 15HC9, and 35AH8 (data not shown). The
coverage of the new deletion in terms of BAC
clones was determined in silico using electronic
PCR and the P1-ends sequence as probes (Fig. 5).
Upon comparing our experimental results with
the Human Genome Browser database (May 2004,
hg 17 assembly, http://genome.ucsc.edu/), we found
a perfect match for the location of all markers. The
new homozygous deletion in GLC20-3p12 is nested
within the 8-Mb deletion of the U2020 cell line and
Figure 5. Summary of results obtained by PCR and ﬁber-FISH experiments, showing the genomic loca-
tion of the GLC20-3p12 homozygous deletion. Rectangles: sequenced ends of P1 clones. Circles: positive
results of speciﬁc PCR experiments indicating ‘‘anchoring points’’ of sequences to one another, used to
build up the contig.
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the 5-Mb deletion of the HCC38 cell line, but it is
much smaller. It partly overlaps the deletion in
H2198, whose exact size has not been determined,
but is known to be internal to DUTT1 (Sundaresan
et al., 1998a). Hence, the same genomic location
contains small deletions (H2198 and GLC20-3p12)
of comparable size in at least two different SCLC
patients.
The New Deletion Harbors Two Previously
Unknown Transcripts—Computational Analysis
Several ESTs (some of which are adenylated)
map within the deleted region in 3p12.3. We focused
on two clusters and chose one from each, namely
W91914 and H51703, for further analysis. Several
SAGE entries support these ESTs that originated
from different cDNA libraries. BLAST searches
with W91914 and H51703 against the human EST
database made it possible to assemble two separate
clusters and analyze their sequence with GenScan
looking for predicted exons.
Cluster ofW91914
The cluster corresponding to the initial probe
W91914 comprised, at the date of submission of
this work, eight ESTs (W91914, W94988, H90477,
H90421, AI078492, AA639329, AA777646, and
CR740005) isolated from fetal liver and spleen,
head and neck carcinoma, and mammary carci-
noma libraries. It is noteworthy that this cluster
aligns (chr3: 78,485,247-79,099,496) with the full-
length mRNA BC017743 (isolated by Mammalian
Gene Collection Program, Imanishi et al., 2004). A
Genscan analysis of this mRNA predicted a puta-
tive exon with an ORF of 49 amino acids, but the
lack of homologues or orthologues in other species
suggests that the transcript is unlikely to code for a
protein. Acembly annotated the gene as a single-
exon transcript of 3.1 kb. Interestingly, the align-
ment of the BC017743 sequence with the chicken
genome produced two hits on Gallus gallus chromo-
some 1, one of which with 86% identity over 353
Figure 6. Fiber-FISH with P1 clones. The yellow spots result from
merging of green and red labeling and show regions of overlap between
two clones. The referral clone P1-27 is centromeric to P1-97. Conse-
quently, the contig is oriented with P1-97 as the most proximal and P1-
80 as the most distal (telomeric) clone. (A) P1-97 and P1-98 showing an
overlap of an estimated size of about 20 kb when hybridized to ﬁbers
from an EBV-transformed lymphoblastoid cell line. (B) P1-98 and P1-80
hardly showing an overlap when hybridized to ﬁbers from the same cell
line. (C) Size comparison between the part of P1-97 hybridizing to
ﬁbers from the cell line GLC20 and the cohybridized cosmid cosD8
(Kok et al., 1995) showing that the part of P1-97 extending beyond the
deletion is somewhat larger than the 40-kb cosmid insert. (D) P1-97
and P1-80 hybridized together with the more centromeric P1-27 to
ﬁbers from the lymphoblastoid cell line, showing the orientation of P1-
97 and P1-80 with respect to the centromere and the 3p telomere.
Since cohybridization of P1-80 and cosD8 to ﬁbers from GLC20 gave a
picture very similar to (C) (i.e., both P1 phages extend about 45 kb
beyond the deletion), the size of the deletion is about 3 3 the P1 insert
size of 80 kb (cf. Fig. 3) minus the overlaps of together about 20 kb
minus the extending P1 parts of about 23 45 kb. Thus the deletion size
is 130 kb.
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residues. Given the recognized importance of micro-
RNAs (miRNAs) in cancer biology (McManus, 2003;
Xu et al., 2004), we looked in the BC017743 sequence
for possible miRNA target sites, which would sug-
gest the existence of a post-transcriptional control
mechanism acting on this transcript. The DIANA
algorithm predicted two possible target sites in the
sequence (Fig. 8A), both scoring in the high-conﬁ-
dence range. Both miRNAs belong to a group of
miRNA genes that were experimentally identiﬁed
and their expression analyzed by Northern blot.
They have a similar sequence originating from dif-
ferent loci. The miRNA has-miR-17-5p derives
from a locus on chromosome 13 and has-miR-106a
from a locus on the X chromosome (Mourelatos et al.,
2002; Dostie et al., 2003; Kasashima et al., 2004;
Suh et al., 2004).
Cluster of H51703
When this work was submitted, the cluster
assembled around the sequence of H51703 was re-
presented by 17 ESTs (H51703, T69773, T70759,
T84499, H40323, H40377, R83269, AA668381,
AA669442, BI598464, BM993003, BX105987,
BE062088, BF746150, BE061843, BF746204, and
CA440361) isolated from different libraries.
Again, this cluster aligned (chr3: 78,485,247-
79,099,496) with a full-length transcript, namely
BC043430 (The Mammalian Gene Collection Pro-
gram, Imanishi et al., 2004). Genscan analysis did
not predict any exon and the small ORFs did not
show similarities with known homologues or ortho-
logues. Acembly annotated this transcript as a puta-
tive single-exon gene of about 1.9 kb, with an ORF
of 46 amino acids, and no known similarities. How-
ever, two bovine ESTs, AV601957 and CR454939,
aligned in correspondence of BC043430 (they showed
92% and 81% identity respectively, in a region free
of repetitive DNA). In the BC043430 sequence,
the DIANA algorithm predicted four putative tar-
get sites for known miRNAs (Fig. 8B), (Houbaviy
et al., 2003; Weber, 2005).
Conservation Analysis of the Deleted Sequence
Aligning the sequence of the GLC20-3p12 dele-
tion with the chicken genome (Bejerano et al.,
2004; Hillier et al., 2004) identiﬁed seven blocks of
highly conserved sequences. Four blocks con-
tained Alu repeats. Two of the four showed 93%
identity between human and chicken, and homol-
ogy with the 7SL chicken gene on chicken chro-
mosome 5. Two other blocks, almost identical to
the previous ones, showed similarities with sequen-
ces on chicken chromosome 2, perhaps representing
another copy of the 7SL gene. Finally, three highly
conserved regions displayed homology with sequen-
ces from the chicken chromosome 1 (numbers refer
Figure 7. Exon 2 of the DUTT1 gene (cDNA 1021-1345, as in Gen-
Bank Z95705) is homozygously deleted in the GLC20-3p12 deletion.
PCR experiments with primers (listed in Table 1) located within exons
at the 50-end of DUTT1. The GLC20-3p12 homozygous deletion bridges
across exon 2 to introns 1 and 2.
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to the human sequence, Human Genome Browser,
May 2004 hg 17 assembly):
Seq5: 69 bp (79000588-79000654), showed 84%
identity between human and chicken.
Seq6: 353 bp (78954642-78954984), showed 86%
identity between human and chicken.
Seq7: 243 bp (79044143-79044377), showed 81%
identity between human and chicken.
None of these regions contained repetitive elements.
Seq6 aligned inside the noncoding transcriptBC017743.
Expression Studies
To independently verify whether the two clus-
ters of ESTs indeed are transcribed, we performed
Northern blot experiments using W91914 and
H51703 cDNA as probes. Under our conditions,
theW91914 probe gave a detectable signal in almost
all tissues tested (two bands of about 2.4 and 3 kb,
Fig. 9A). TheH51703 probe yielded a band of about
2 kb in pancreas, one of about 3 kb in skeletal mus-
cle, and one of about 1.35 kb in liver (Fig. 9B). RT-
PCR experiments performed with primers located
in W91914 and H51703 conﬁrmed that these se-
quences were expressed in various normal organs
(Fig. 9C). Analysis of W91914 expression in SCLC
cell lines (Fig. 9C) showed that, with the exception
of GLC20, the gene was possibly expressed at
greater than normal levels. A similar result was
seen for H51703 (Fig. 9C). Next, we investigated
with quantitative real-time PCR, the relative ex-
pression level of W91914 in a set of normal/tumor
paired samples (Table 2) represented by breast car-
cinoma, NSCLC, and clear-cell kidney carcinoma
(RCC). (H51703 was not analyzed because of tech-
nical constraints). W91914 was found overexpressed
in three of four analyzed lung cancer biopsies (75%).
Figure 9. Expression studies of ESTs W91914 and H51703, chosen as
representative of two EST clusters located in the region affected by the
GCL20-3p12 homozygous deletion. (A) and (B), Northern blots. Probes:
W91914 (A) and H51703 (B). Arrows indicate bands highlighted by the re-
spective probes. RT-PCR with primers for BC017743 (W91914, 215 bp) in
(C), for BC043430 (H51703, 223 bp) in (D), for Beta-2-microglobulin (80 bp)
in (E). Template: cDNAs from various organs and SCLC cell lines. H: heart, Br:
brain, Pl: placenta, Lu: lung, Li: liver, SM: skeletal muscle, K: kidney, Pc: pan-
creas, and SLCS GLC cell lines. GLC20: cell line in which BC017743 and
BC043430 are homozygously deleted. Blank: no-cDNA control.
Figure 8. Human microRNAs that
putatively hit target sequences on (A)
BC017743 and (B) BC043430 tran-
scripts (adapted from a window of the
DIANA algorithm results (http://diana.
pcbi.upenn.edu/cgi-bin/micro_t.cgi).
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However, it was found underexpressed in four of
six RCC samples (66.67%) and in six of ten breast
cancer biopsies (60%), (Fig. 10). These results show
that BC017743 (represented byW91914) and BC043430
(represented by H51703) are differentially expressed
in tumor biopsies and cancer cell lines when com-
pared with normal tissues.
By means of RT-PCR experiments using primers
located within genomic sequence or across splice
sites (AP43R, Sulimova et al., 2002; and pyruvate
dehydrogenase beta PDHB, primer sequence in
Table 1), all cDNA samples were tested and found
to be free of genomic DNA (data not shown).
DISCUSSION
Detection of homozygous deletions and subse-
quent microsatellite mapping to identify allelic loss
and deletion boarders remains the most powerful
method to localize putative TSGs. Interstitial dele-
tions in the low gene-density chromosome region
3p12 have been reported in lung and other malig-
nancies (Daly et al., 1991; Ganly et al., 1992; Pandis
et al., 1993). The U2020 region at chromosome band
3p12.3, in particular, has been strongly suspected to
harbor a TSG. Since the mid 1990s, karyotype anal-
ysis has shown that deletions in 3p12 are the only
evident abnormality in cells cultured from the nor-
mal bronchial epithelial cells of lung cancer patients
(Sundaresan et al., 1995). Sanchez et al. (1994)
showed that the introduction of two centromeric
fragments of 3p (encompassing 3p12-q24 and
3p14-q11) into a highly malignant renal cell carci-
noma (RCC) cell line resulted in a dramatic sup-
pression of tumor growth in athymic nude mice.
This suggested that a locus in this region con-
trolled the growth of RCC cells by inducing rapid
cell death in vivo. Lott et al. (1998) and Lovell
et al. (1999) demonstrated that a fragment of human
chromosome 3, overlapping with the U2020 dele-
tion, mediated rapid cell death and tumor growth
suppression of RCC cells in vivo. However, dele-
tion of this region was associated with the immor-
talization of human uroepithelial cells (Vieten
et al., 1998).
Detailed mapping determined that the U2020
deletion was about 8 Mb in size (Drabkin et al.,
1992; Latif et al., 1992), and it harbors the smaller
deletions HCC38 and H2198 (Sundaresan et al.,
1998a). Sundaresan et al. (1998b) cloned a gene
disrupted by these deletions: DUTT1. DUTT1 is an
integral membrane protein. It is an axon guidance/
cell adhesion receptor whose best-characterized
function is to regulate the decision by axons to
cross the central nervous system midline. DUTT1
is widely expressed as an about 8-Kb mRNA, and
two transcript variants are known that differ in
their 50 terminal end (start site and ﬁrst exon). The
H2198 deletion affects exon 2 (encoding the ﬁrst
Ig domain) of the DUTT1-short variant. Introduc-
tion of this mutation in the mouse germ line (Xian
et al., 2001) generates animals that in the homozy-
gous state frequently die at birth of respiratory fail-
ure due to functional immaturity of lungs. Survi-
vors acquire bronchial epithelial abnormalities sim-
ilar to those involved in the early stages of lung
cancer and die in the ﬁrst year of life (Xian et al.,
2001). Heterozygous mice grow normally, but spon-
taneously develop lymphomas and carcinomas in
their second year of life, with a threefold increase
in incidence compared with controls (Xian et al.,
2004). Invasive lung adenocarcinoma is by far the
predominant carcinoma. In addition to the mutant
allele, loss of heterozygosity (LOH) analysis indi-
cates that these tumors retain the structurally nor-
mal allele but with substantially increased methyl-
ation of their promoter region (Xian et al., 2004).
Dallol et al. (2002) determined that the DUTT1
promoter was hypermethylated in 19% of primary
invasive breast carcinomas, in 18% of primary clear
cell renal cell carcinomas (CC-RCC), and in 4% of
primary NSCLC tumors. In addition, 80% of breast
carcinomas and 75% of CC-RCC containing DUTT1
hypermethylation also show allelic loss at 3p12.
TABLE 2. Description of the Human Tumor Samples Analyzed
in This Study
Sample Sex Age Histology Stage
Breast carcinoma
BC16 f 53 Ductal, md II a
BC17 f 53 Ductal, ld II b
BC19 f 49 Ductal, md II a
BC20 f 68 Ductal, ld III b
BC21 f 65 Lobular, md I
BC22 f 55 Ductal, md II a
BC12 f 50 Ductal, md II a
BC13 f 56 Ductal, md II a
BC14 f 56 Ductal, md II b
BC33 f 63 Ductal, md II
Non-small cell lung carcinoma
LC01 m 52 Adenocarcinoma, hd I
LC02 m 56 Squamous cell, ld IV
LC03 m 58 Adenocarcinoma, ld IV
LC04 f 64 Adenocarcinoma, ld IV
Clear cell renal cell carcinoma
RCC02 f 57 CC-RCC, ld IV
RCC06 m 63 CC-RCC, ld IV
RCC10 m 57 CC-RCC, ld III
RCC11 f 59 CC-RCC, md II
RCC12 f 35 CC-RCC, hd I
RCC13 f 54 CC-RCC, md II
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This suggests that DUTT1 is a classic TSG requir-
ing inactivation of both alleles to elicit tumorigene-
sis. However, an extensive mutation analysis of
DUTT1 in lung, breast, and kidney cancers did not
reveal inactivating mutations (Dallol et al., 2002).
Here, we report the identiﬁcation of a new
homozygous deletion in the lung cancer cell line
GLC20. Located at 3p12.3, it affects the second
exon of DUTT1 and spans about 110–130 kb, per-
haps the smallest described thus far in this region.
Moreover, using molecular biology and bioinfor-
matics methods, we identiﬁed two novel putative
genes, BC017743 and BC043430, that reside in the
second intron of DUTT1 and, therefore, are also
lost in the deletion. None of the transcripts showed
obvious splicing signals; but, in our experiments,
each displayed slightly different bands in Northern
blot analysis. Both had a polyA tail and small ORFs
that are unlikely to encode proteins according to
comparative genomic analyses. On the bases of
these characteristics, we conclude that they repre-
sent possibly mRNA-like ncRNAs (Erdmann et al.,
2000; Tupy et al., 2005). Transcribed by RNA po-
lymerase II, in absence of protein products, these
types of RNAs serve as riboregulators or regulators
of expression of related genes (Erdmann et al.,
2000; Numata et al., 2003; Tupy et al., 2005).
Based on their sequence, BC017743 and
BC043430 seemingly lack homologues or ortho-
logues, a feature that has been reported for other
known genes and ncRNAs (Conrad et al., 2002;
Weber, 2005). Also, some biologically important
ncRNA families show that, inside each group, con-
servation of secondary structure has a higher signif-
icance than conservation of primary sequence
(Weinberg and Ruzzo, 2004). BC017743 and
BC043430 represent the ﬁrst ncRNA transcripts/
genes found in a homozygous cancer deletion
affecting the 3p12.3 region.
To date, very few cases of independent tran-
scription units embedded inside introns have been
described. The genes EV12A and EV12B are en-
coded by one intron of the human neuroﬁbromatosis
type I (NF1) gene and are transcribed in the oppo-
site direction. However, their products are func-
tionally unrelated to NF1.
The Ach transporter gene, transcribed from the
ﬁrst intron of the rat ChAT gene (Bejanin et al.,
1994) and the Saitohin gene, transcribed from in-
tron 9 of the human tau gene (Conrad et al., 2002)
are different, as both are transcribed in the same
orientation and are functionally related to the lon-
ger gene in which they are harbored. The number
of such cases is likely to increase given recent
reports showing that 233,303 clusters of ESTs are
totally contained within intronic regions (Reis et al.,
2005).
Both BC017743 and BC043430 are transcribed in
the same direction as DUTT1, suggesting that their
product could be co-regulated and possibly related
to DUTT1 function.
It will be interesting to verify whether both tran-
scripts are actually under post-transcriptional con-
trol by the miRNAs whose putative target sites
were predicted in their sequence. Since the loss of
BC017743 and BC043430 was found associated
with a tumor phenotype, one might argue that both
transcripts exert a tumor suppressor action, possi-
bly mediated by the miRNA action. In fact, several
cases are now known (McManus, 2003; Xu et al.,
2004; Calin et al., 2005), where changes in the ex-
pression level of miRNAs may affect the control of
cell growth or survival, and be, therefore, involved
with cancer onset or progression.
Figure 10. qRT-PCR Expression
analysis of BC017743 (W91914) in can-
cer biopsies and normal related tissues.
The Y axis indicates the expression
value shown in log 10 scale relative to
control normal tissues normalized to 1.
The X axis shows the sample names.
The comparative DDCt method was
used as described (Senchenko et al.,
2003) to analyze the qRT-PCR results.
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Noteworthy, the miRNA hsa-mir-17-5p at 13q31.3
(http://www.ensembl.org/Homo_sapiens/contigview?
highlight¼&chr¼ 13&vc_start¼ 90700860&vc_end
¼ 90900943) is contained within a region frequently
lost in breast cancer progression (Eiriksdottir et al.,
1998), leading one to speculate that LOH at a miRNA
locus (e.g. hsa-mir-17-5p) might lead to the same effect
as LOH at the miRNA target site (conceivably
BC017743 and BC043430 in the case of lung, breast,
or kidney cancer). Moreover, hsa-mir-17-5pwas shown
to be down-regulated following differentiation in-
duced by TPA treatment of HL-60 promyelocytic
leukemia cells (Kasashima et al., 2004). This sug-
gests that miRNA-induced control of cell differen-
tiation might consist of two distinct mechanisms:
(i) a mechanism of gene silencing through up-regu-
lation of miRNAs and (ii) a mechanism of gene
activation through termination of miRNA-regu-
lated gene silencing. Similarly, it would be inter-
esting to investigate whether LOH at 11q23 in
lung cancer involves not only loss of the TSLC1
gene that resides there (Kuramochi et al., 2001),
but also loss of the locus encoding hsa-mir-34b,
which putatively regulates BC043430 (as well as
other targets in the genome probably; it was
shown, for example, that reduced levels of hsa-mir-
15a and hsa-mir-16 are a trait shared by different
forms of lymphomas and leukemias; Calin et al.,
2002; Eis et al., 2005).
A situation diametrically opposed to that
described in the GLC20-3p12 deletion is given by
the accumulation of the ncRNA BIC (Eis et al.,
2005). The BIC transcript is polyadenylated and
has short putative ORFs that are not conserved.
Most likely, BIC does not encode a protein. How-
ever, a phylogenetically conserved region of BIC
was indeed shown to encode a miRNA, mir-155,
whose accumulation strongly correlates with an
aggressive B cell neoplasm (Eis et al., 2005).
The GLC20-3p12 deletion might also harbor
miRNA loci. Recently, a list of computationally
identiﬁed human miRNA genes was reported,
some of which are encoded at 3p12 (Berezikov
et al., 2005). One of them (cand893 HS3, 78.768.573-
78.768.661 R, whose closest experimentally identi-
ﬁed miRNA is M. musculus mmu-mir-297) is harbored
inside the deletion (Houbaviy et al., 2003). Further
studies are however necessary to investigate whether
DUTT1 itself is a target for this miRNA.
We were also able to analyze the degree of con-
servation of the noncoding sequence around exon
2 of DUTT1. This region contains at least three
blocks of extremely conserved, nonrepetitive sequence,
spanning 353, 69, and 243 bp respectively, with an
identity ranging from 81% to 86% between the
human and chicken genome.
In conclusion, it is interesting to note that the
two smallest, partly overlapping homozygous dele-
tions described at 3p12.3 (that is, H2198 (Sundaresan
et al., 1998a), and the one described here) remove,
besides one exon of DUTT1, two intronic ncRNA
genes. Their presence, along with several short
noncoding regions highly conserved between human
and chicken genomes (Bejerano et al., 2004; Hillier
et al., 2004), suggests that the effect of the 3p12
deletion might be complex.
The expression analysis of BC017743 (W91914)
showed that, while it is under-expressed in most
breast and kidney tumors analyzed, it is also over-
expressed in a variety of SCLC and NSCLC sam-
ples (represented by tumor biopsies and cell lines).
Because of technical impediments, the expression
of BC043430 (H51703) could only be analyzed in
lung cancer cell lines only, where it was found to
be over-expressed.
Several hypotheses can be suggested regarding
their possible role in initiating or promoting cancer
growth. Because of their location in a classical tu-
mor suppressor region, it is possible that they rep-
resent true candidate TSGs. This hypothesis is
supported by their under-expression in kidney and
breast carcinomas. Epigenetic inactivation of DUTT1
due to hypermethylation is a frequent event in
breast carcinomas and clear-cell renal cell carcino-
mas, but rare in NSCLC and not detectable in
SCLC (Dallol et al., 2002). Eventhough the nc-
RNA genes do not have CpG promoters, they are
transcribed in the same direction as DUTT1. This
suggests that the local hypermethylation that affects
the DUTT1 promoter in some cancers (Dallol et al.,
2002) might concomitantly be responsible for their
decreased expression, whether or not they are func-
tionally correlated to DUTT1.
However, both genes were also found to be con-
sistently over-expressed in lung cancer specimens
of different histology. Because of their genomic
location with respect to DUTT1, it is possible that
BC017743 or BC043430 modulate DUTT1 function.
It has been reported that other ncRNA genes mod-
ulate the gene in whose intron they are located
(Bejanin et al., 1994; Conrad et al., 2002). If their
function is to down-regulate DUTT1, their over-
expression (caused by a mutation elsewhere in the
genome) would have an oncogenic potential. In
fact, at least for the GLC20 cell line, it is important
to note that another element of complexity is the
presence of a second homozygous deletion present
at 3p21.3 (Kok et al., 1994). Indeed, with respect to
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the short arm of chromosome 3, it has been sug-
gested for several types of tumor, that multiple de-
letions, coexisting but with different 3p locations,
may have a synergistic effect in driving tumorigene-
sis (Van den Berg et al., 1997; Senchenko et al.,
2003). Finally, it cannot be ruled out that BC017743
and BC043430 might not have any causative or pro-
moting role in cancer. However, it remains striking
how their expression consistently changes in kidney
and lung cancers even though in opposite directions.
Further mutation and functional studies of the
two ncRNA genes, BC043430 and BC017743, will
be critical for understanding their possible role in
initiating or promoting cancer development.
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